临床神经病学杂志2012，Vol.25Issue(3)：161-164,4.
中国缺血性脑卒中患者抗血小板药物的应用现状
Application status of antiplatelet agents in Chinese patients with ischemic stroke
冯芳 1李静 1李希 1CHENYi-ping 2CHENZheng-ming 2LANDRAYMartin 2ARMITAGEJane 2蒋立新1
作者信息
- 1. 100191,北京,中国医学科学院北京协和医学院国家心血管病研究所阜外心血管病医院
- 2. 英国牛津大学临床试验与流行病学研究中心
- 折叠
摘要
Abstract
Objective To investigate the application status of antiplatelet agents in Chinese patients with ischemic stroke (IS) and related factors of influence the drug use. Methods The basic data and application status of antiplatelet agents in IS patients with course > 3 months in the north, central and eastern of our country 14 cities were investigated and analyzed. Results There were 6422 IS patients were involved,and all of them had the indication of using antiplatelet agents, but only 72. 4% patients (4652 cases) were using antiplatelet agents. Among those IS patients using antiplatelet agents, 98. 7% was using Aspirin. The taking rate of antiplatelet agents in patients with course ≥3 years (64. 0% ) was significant lower than shose course < 1 year ( 72. 0% ) (P < 0. 001) . The proportion of using antiplatelet agents in IS patients combined with coronary heart disease or hypertension were significantly higher than IS patients without those complications (all P < 0. 001 ). Conclusion There is a gap between the application status of antiplatelet agents in Chinese IS patients and the secondary prevention guidelines recommending that require all of the IS patients should use antiplatelet agents, sepecialy in IS patients with longer course.关键词
抗血小板药/缺血性脑卒中/二级预防Key words
antiplatelet agents/ ischemic stroke/ secondary prevention分类
医药卫生引用本文复制引用
冯芳,李静,李希,CHENYi-ping,CHENZheng-ming,LANDRAYMartin,ARMITAGEJane,蒋立新..中国缺血性脑卒中患者抗血小板药物的应用现状[J].临床神经病学杂志,2012,25(3):161-164,4.
